Cover Image
Market Research Report

Global Drug Infusion Systems Market: Focus on Products, Application, Competitive Landscape and 57 Countries - Analysis and Forecast 2017-2025

Published by BIS Research Private Limited Product code 609627
Published Content info 355 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Drug Infusion Systems Market: Focus on Products, Application, Competitive Landscape and 57 Countries - Analysis and Forecast 2017-2025
Published: March 2, 2018 Content info: 355 Pages
Description

The global drug infusion systems market was estimated to be $8.1 billion in 2016 and is estimated to grow over $14.7 billion by 2025. The rise in the geriatric population along with the increased prevalence of chronic diseases is expected to boost the demand for drug infusion systems and drive the global market towards rapid growth. The drug infusion systems market presents with opportunities to change the treatment options according to the needs of the patient.

The increased prevalence of chronic diseases and the rising geriatric population has led to the high demand for better medicines and facilities. For the continued and improved care of the patients, the drug infusion systems are being extensively used in the hospitals as well as the home care settings.

As per the Arthritis Foundation, the older population in the U.S. affected by arthritis is estimated to grow to 21% by 2040, from the current value of 15%. The rising prevalence of chronic diseases is another factor contributing to the growth of the market. In the recent years, the prevalence of chronic diseases has been increasing irrespective of the age. As per the World Health Organization (WHO), the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. The prevalence of genetic diseases, and cancer has also witnessed a rise in the recent years.

As per the U.S. FDA an infusion pump is a medical device that delivers controlled amounts of fluids such as nutrients and medication.

The drug infusion systems market includes various infusion systems products including the components such as pumps, accessories and disposables. The market includes several products such as large volume pumps, enteral pumps, syringe pumps, insulin pumps, elastomeric pumps, Patient controlled Analgesia (PCA), ambulatory pumps, and implantable pumps, among many others. These devices are being used for the administration of fluids and medication to a number of diseases, and therapeutic areas such as diabetes, analgesia, nutrition, haematology, oncology and paediatrics. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.

The purpose of the study is to gain a holistic view of the drug infusion systems market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the solutions allied with the drug infusion systems market. The market has been segmented into ‘product', ‘application', ‘end users' and ‘geographical regions'. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market, and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into the consideration before entering the market.

This research report aims at answering various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global drug infusion systems market, and assesses the factors governing the same.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, challenges, and opportunities in the global drug infusion systems market?
  • How did the drug infusion systems market evolve, and what is its scope in the future?
  • What is the market share of the leading segments, and sub-segments of the global drug infusion systems market in the period 2016-2025?
  • How will each segment of the global drug infusion systems market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2025?
  • What are the influencing factors that may affect the market share of the key players?
  • What are the key developmental strategies implemented by the key players to stand out in this market?
  • What is the infusion systems market value in different countries of the world?
  • What will be the growth rate of the insulin infusion systems during the forecast period?
  • Which product segment is expected to register the highest CAGR for the drug infusion systems market?
  • How has the market been segmented on the basis of application? Which application segment has the largest share, and growth rate in the drug infusion systems market?
  • How the homecare segment among the end users will grow in the period 2016-2025?
  • Which geographical region will contribute to the highest sales of drug infusion systems?

The key players that have been contributing significantly to the drug infusion systems market are Becton, Dickinson & Company, Caesarea Medical Electronics Ltd, Debiotech, Medtronic, Flowonix Medical Inc., Fresenius SE & Co. KGaA, ICU Medical, Insulet Corporation, IRADIMED CORPORATION, MOOG, Smiths Group, Tandem Diabetes care, and Terumo Corporation, among others.

Table of Contents
Product Code: BH047A

Table of Contents

Executive Summary

1. Market Overview

  • 1.1. Introduction
  • 1.2. Definition and Characterization
  • 1.3. Infusion Systems Application
  • 1.4. Market Size and Growth Potential
  • 1.5. Technology Advancements
  • 1.6. Pricing Analysis
  • 1.7. Recent Product Launches

2. Market Dynamics

  • 2.1. Market Drivers
  • 2.2. Market Challenges
  • 2.3. Market Opportunities

3. Industry Insights

  • 3.1. Regulatory Scenario
  • 3.2. Patent Landscape

4. Competitive Landscape

  • 4.1. Share of Different Strategies
  • 4.2. Porter's Five Force Analysis
  • 4.3. Market Share Analysis

5. Global Drug Infusion Systems Market, By Product

  • 5.1. Introduction & Different Components of a Drug Infusion System
  • 5.2. Market Segment
  • 5.3. Large Volume Infusion Systems
  • 5.4. Patient Controlled Analgesia
  • 5.5. Elastomeric Infusion Pumps
  • 5.6. Insulin Infusion Pumps
  • 5.7. Syringe Infusion Systems
  • 5.8. Implantable Infusion Systems
  • 5.9. Ambulatory Infusion Systems
  • 5.10. Enteral Infusion Systems

6. Global Drug Infusion Systems Market, by Application

  • 6.1. Introduction
  • 6.2. . Oncology/Chemotherapy
  • 6.3. Diabetes
  • 6.4. Analgesia
  • 6.5. Nutrition
  • 6.6. Haematology
  • 6.7. Paediatrics
  • 6.8. Other Applications

7. Global Drug Infusion Systems Market, By End User

  • 7.1. Introduction
  • 7.2. Different Types of End Users

8. Global Drug Infusion Systems Market, By Region

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. The U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Austria
    • 8.3.2. Belarus
    • 8.3.3. Belgium
    • 8.3.4. Denmark
    • 8.3.5. Finland
    • 8.3.6. France
    • 8.3.7. Germany
    • 8.3.8. Greece
    • 8.3.9. Hungary
    • 8.3.10. Ireland
    • 8.3.11. Italy
    • 8.3.12. Luxembourg
    • 8.3.13. Netherlands
    • 8.3.14. Norway
    • 8.3.15. Poland
    • 8.3.16. Portugal
    • 8.3.17. Russia
    • 8.3.18. Spain
    • 8.3.19. Sweden
    • 8.3.20. Switzerland
    • 8.3.21. Turkey
    • 8.3.22. Ukraine
    • 8.3.23. The U.K.
  • 8.4. Asia Pacific
    • 8.4.1. Australia
    • 8.4.2. Bangladesh
    • 8.4.3. China
    • 8.4.4. Hong Kong
    • 8.4.5. India
    • 8.4.6. Indonesia
    • 8.4.7. Japan
    • 8.4.8. South Korea
    • 8.4.9. Malaysia
    • 8.4.10. New Zealand
    • 8.4.11. Pakistan
    • 8.4.12. Philippines
    • 8.4.13. Singapore
    • 8.4.14. Taiwan
    • 8.4.15. Thailand
    • 8.4.16. Vietnam
  • 8.5. Latin America & Middle East & Africa
    • 8.5.1. Argentina
    • 8.5.2. Brazil
    • 8.5.3. Chile
    • 8.5.4. Colombia
    • 8.5.5. Mexico
    • 8.5.6. Egypt
    • 8.5.7. Iran
    • 8.5.8. Israel
    • 8.5.9. Kenya
    • 8.5.10. Kuwait
    • 8.5.11. Nigeria
    • 8.5.12. Oman
    • 8.5.13. Qatar
    • 8.5.14. Saudi Arabia
    • 8.5.15. South Africa
    • 8.5.16. United Arab Emirates

9. Company Profiles

  • 9.1. Acromed AG
    • 9.1.1. Overview
    • 9.1.2. Acromed AG: Corporate Summary
    • 9.1.3. Acromed AG: Product Portfolio
    • 9.1.4. Acromed AG: SWOT Analysis
  • 9.2. B. Braun Melsungen AG
    • 9.2.1. Overview
    • 9.2.2. B. Braun Melsungen AG: Overall Product Portfolio
    • 9.2.3. Financials
      • 9.2.3.1. Financial Summary
    • 9.2.4. Global Presence
    • 9.2.5. Recent Developments
    • 9.2.6. B.Braun Melsungen AG: SWOT Analysis
  • 9.3. . Baxter International Inc.
    • 9.3.1. Overview
    • 9.3.2. Baxter International Inc.: Product Portfolio
    • 9.3.3. Financials
      • 9.3.3.1. Financial Summary
    • 9.3.4. Global Presence
    • 9.3.5. Recent Developments
    • 9.3.6. Baxter International Inc.: SWOT Analysis
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Overview
    • 9.4.2. Becton, Dickinson and Company: Product Portfolio
    • 9.4.3. Financials
      • 9.4.3.1. Financial Summary
    • 9.4.4. Global Presence
    • 9.4.5. Recent Development
    • 9.4.6. Becton, Dickinson and Company: SWOT Analysis
  • 9.5. Caesarea Medical Electronics Ltd.
    • 9.5.1. Overview
    • 9.5.2. Corporate Summary
    • 9.5.3. Caesarea Medical Electronics Ltd.: Product Portfolio
    • 9.5.4. Caesarea Medical Electronics: SWOT Analysis
  • 9.6. Debiotech S.A.
    • 9.6.1. Overview
    • 9.6.2. Corporate Summary & Product Portfolio
    • 9.6.3. Debiotech S.A.: SWOT Analysis
  • 9.7. Flowonix Medical Inc.
    • 9.7.1. Overview
    • 9.7.2. Corporate Summary & Product Portfolio
    • 9.7.3. Recent Developments
    • 9.7.4. Flowonix Medical Inc.: SWOT Analysis
  • 9.8. Fresenius SE & Co. KGaA
    • 9.8.1. Overview
    • 9.8.2. Fresenius Kabi: Product Portfolio
    • 9.8.3. Financials
      • 9.8.3.1. Financial Summary
    • 9.8.4. Global Presence
    • 9.8.5. Recent Developments
    • 9.8.6. Fresenius SE & Co. KGaA: SWOT Analysis
  • 9.9. Halyard Health, Inc.
    • 9.9.1. Overview
    • 9.9.2. Halyard Health,Inc.: Overall Product Portfolio
    • 9.9.3. Financials
      • 9.9.3.1. Financial Summary
    • 9.9.4. Global Presence
    • 9.9.5. Halyard Health, Inc.: SWOT Analysis
  • 9.10. ICU Medical Inc.
    • 9.10.1. Overview
    • 9.10.2. ICU Medical Inc.: Product Portfolio
    • 9.10.3. Financials
      • 9.10.3.1. Financial Summary
    • 9.10.4. Global Presence
    • 9.10.5. Recent Developments
    • 9.10.6. ICU Medical Inc.: SWOT Analysis
  • 9.11. IRADIMED CORPORATION
    • 9.11.1. Overview
    • 9.11.2. IRADIMED CORPORATION: Product Portfolio
    • 9.11.3. Financials
      • 9.11.3.1. Financial Summary
    • 9.11.4. Global Presence
    • 9.11.5. Recent Developments
    • 9.11.6. IRADIMED CORPORATION: SWOT Analysis
  • 9.12. Insulet Corporation
    • 9.12.1. Overview
    • 9.12.2. Insulet Corporation: Product Portfolio
    • 9.12.3. Financials
      • 10.12.3.1. Financial Summary
    • 9.12.4. Global Presence
    • 9.12.5. Recent Developments
    • 9.12.6. Insulet Corporation: SWOT Analysis
  • 9.13. Medtronic Public Limited Company
    • 9.13.1. Overview
    • 9.13.2. Medtronic Public Limited Company: Product Portfolio
    • 9.13.3. Financials
      • 9.13.3.1. Financial Summary
    • 9.13.4. Global Presence
    • 9.13.5. Medtronic Public Limited Company: SWOT Analysis
  • 9.14. MOOG, Inc.
    • 9.14.1. Overview
    • 9.14.2. MOOG, Inc.: Product Portfolio
    • 9.14.3. Financials
      • 9.14.3.1. Financial Summary
    • 9.14.4. Global Presence
    • 9.14.5. Recent Developments
    • 9.14.6. MOOG, Inc.: SWOT Analysis
  • 9.15. Smiths Group plc
    • 9.15.1. Overview
    • 9.15.2. Smiths Group plc: Product Portfolio
    • 9.15.3. Financials
      • 9.15.3.1. Financial Summary
    • 9.15.4. Global Presence
    • 9.15.5. Recent Developments
    • 9.15.6. Smiths Group plc: SWOT Analysis
  • 9.16. Tandem Diabetes Care, Inc.
    • 9.16.1. Overview
    • 9.16.2. Tandem Diabetes Care, Inc.: Product Portfolio
    • 9.16.3. Financials
      • 9.16.3.1. Financial Summary
    • 9.16.4. Global Presence
    • 9.16.5. Recent Developments
    • 9.16.6. Tandem Diabetes Care, Inc.: SWOT Analysis
  • 9.17. Terumo Corporation
    • 9.17.1. Overview
    • 9.17.2. Terumo corporation: Product Portfolio
    • 9.17.3. Financials
      • 9.17.3.1. Financial Summary
    • 9.17.4. Global Presence
    • 9.17.5. Terumo Corporation: SWOT Analysis
  • 9.18. Zyno Medical, LLC
    • 9.18.1. Overview
    • 9.18.2. Corporate Summary
    • 9.18.3. Zyno Medical, LLC: Product Portfolio
    • 9.18.4. Recent Developments
    • 9.18.5. Zyno Medical, LLC: SWOT Analysis
  • 9.19. Snapshot of Other Key Players: Ivenix, Inc.

10. Report Scope

  • 10.10.1. Scope of the Report
  • 10.10.2. Global Drug Infusion Systems Market Segmentation
  • 10.10.3. Research Methodology
    • 10.10.3.1. Primary Research
    • 10.10.3.2. Secondary Research
    • 10.10.3.3. Key Data Points From Primary Sources
    • 10.10.3.4. Key Data Points From Secondary Sources
    • 10.10.3.5. Data Triangulation
    • 10.10.3.6. Top-Down Approach (Segmental Analysis)
    • 10.10.3.7. Bottom-Up Approach (Segmental Analysis)
  • 10.10.4. Assumptions & Limitations

List of Tables

  • 1. Drug Infusion Systems Market, The U.S. vs China
  • 2. Recent Product Launches
  • 3. Global Regulatory Scenario
  • 4. Patent Landscape
  • 5. Examples of Marketed Large Volume Infusion Pumps
  • 6. Examples of Marketed PCA Pumps
  • 7. Examples of Marketed Syringe Infusion Systems
  • 8. Global Infusion Pumps Market, by Country 2016-2025 ($Million)
  • 9. Global Infusion Disposables Market, by Country 2016-2025 ($Million)
  • 10. Global Infusion Accessories Market, by Country 2016-2025 ($Million)
  • 11. Percentages of Population Aged 60 Years and Above
  • 12. Arcomed AG: Overview
  • 13. B. Braun Melsungen AG: Overview
  • 14. B. Braun Melsungen AG: Recent Developments
  • 15. Baxter International: Overview
  • 16. Baxter International: Product Developments
  • 17. Baxter International: Awards & Recognition
  • 18. Becton, Dickinson and Company: Overview
  • 19. Becton, Dickinson and Company: Product Development
  • 20. Caesarea Medical Electronics Ltd.: Overview
  • 21. Debiotech S.A.: Overview
  • 22. Flowonix Medical Inc.: Overview
  • 23. Flowonix Medical Inc.: Product Development
  • 24. Fresenius SE & Co. KGaA: Overview
  • 25. Fresenius SE & Co. KGaA: Recent Developments
  • 26. Halyard Health, Inc.: Overview
  • 27. ICU Medical Inc.: Overview
  • 28. ICU Medical Inc.: Recent Developments
  • 29. IRADIMED CORPORATION: Overview
  • 30. IRADIMED CORPORATION: Recent Development
  • 31. Insulet Corporation: Overview
  • 32. Insulet Corporation: Acquisitions, Collaborations, and Agreements
  • 33. Medtronic Public Limited Company: Overview
  • 32. MOOG, Inc.: Overview
  • 33. MOOG, Inc.: Product Developments
  • 34. Smiths Group plc: Overview
  • 35. Smiths Group plc: Recent Developments
  • 36. Tandem Diabetes Care, Inc.: Overview
  • 37. Tandem Diabetes Care, Inc.: Recent Developments
  • 38. Terumo Corporation: Overview
  • 39. ZynoMedical, LLC: Overview
  • 40. Zyno Medical, LLC: Recent Developments
  • 41. Ivenix, Inc.: Overview

List of Figures

  • 1. Chronic Conditions: Key Statistics: 2016
  • 2. Market Drivers and Challenges
  • 3. Global Drug Infusion Systems Market, by Components, 2016
  • 4. Global Drug Infusion Systems Market, by Components, 2025
  • 5. Global Drug Infusion Systems Market, by Infusion System Type, 2016
  • 6. Global Drug Infusion Systems Market, by Infusion System Type, 2025
  • 7. Global Drug Infusion Systems Market, by Application, 2016
  • 8. Global Drug Infusion Systems Market, by Application, 2025
  • 9. Global Drug Infusion Systems Market, by End User, 2016
  • 10. Global Drug Infusion Systems Market, by End User, 2025
  • 11. Global Drug Infusion Systems Market, by Region, 2016
  • 12. Global Drug Infusion Systems Market, by Region, 2025
  • 13. Global Drug Infusion Systems Market
  • 14. Market Share Analysis
  • 15. Advantages of Drug Infusion Systems
  • 16. Desirable Characteristics of Drug Infusion Systems
  • 17. Global Drug Infusion Systems Market Size & Growth Potential, by Product Type
  • 18. Global Drug Infusion Systems Market Size & Growth Potential, by End User
  • 19. Global Drug Infusion Systems Market Size & Growth Potential, by Application
  • 20. Number of People with Chronic Conditions (U.S.) in Million
  • 21. Infusion Pump Recalls, 2010-2017
  • 22. Per Day Cost Savings vs. Hospitals
  • 23. Share of Different Strategies
  • 24. Porter's Five Forces Analysis
  • 25. Market Share Analysis
  • 26. Components of Drug Infusion Systems
  • 27. Global Drug Infusion Systems Market, by Components
  • 28. Segmentation of Global Drug Infusion Systems Market, By Product
  • 29. Global Drug Infusion Systems Market, by Product, 2016-2025 ($Million)
  • 30. Global Large Volume Infusion Systems Market, 2016-2025 ($Million)
  • 31. Global PCA Infusion Systems Market, 2016-2025 ($Million)
  • 32. Global Elastomeric Infusion Systems Market, 2016-2025 ($Million)
  • 33. Global Insulin Infusion Systems Market, 2016-2025 ($Million)
  • 34. Global Syringe Infusion Systems Market, 2016-2025 ($Million)
  • 35. Global Implantable Infusion Systems Market, 2016-2025 ($Million)
  • 36. Advantages & Disadvantages of Implantable Infusion Systems
  • 37. Global Ambulatory Infusion Systems Market, 2016-2025 ($Million)
  • 38. Global Enteral Infusion Systems Market, 2016-2025 ($Million)
  • 39. Applications of Infusion Systems
  • 40. Global Drug Infusion Systems Market, by Application, 2016-2025 ($Million)
  • 41. Global Oncology Infusion Systems Market, 2016-2025, ($Million)
  • 42. Number of New Cancer Cases
  • 43. Types of Diabetes Mellitus
  • 44. Global Patients Diagnosed with Diabetes
  • 45. Global Diabetes Infusion Systems Market, 2016-2025, ($Million)
  • 46. Global Analgesia Infusion Systems Market, 2016-2025, ($Million)
  • 47. Most Common Types of Chronic Pain
  • 48. Global Nutrition Infusion Systems Market, 2016-2025, ($Million)
  • 49. Global Haematology Infusion Systems Market, 2016-2025, ($Million)
  • 50. Global Paediatrics Infusion Systems Market, 2016-2025, ($Million)
  • 51. Global Others Infusion Systems Market, 2016-2025, ($Million)
  • 52. Global Drug Infusion Systems Market, End User
  • 53. Global Drug Infusion Systems Market, by End User, 2016-2025 ($Million)
  • 54. Global Drug Infusion Systems Market, by Region, 2016-2025 ($million)
  • 55. North America Drug Infusion Systems Market 2016-2025 ($Million)
  • 56. North America Drug Infusion Systems Market, by Components 2016-2025 ($Million)
  • 57. The U.S. Drug Infusion Systems Market, by Value, 2016-2025 ($million)
  • 58. The U.S. Drug Infusion Systems Market, by Type 2016-2025($million)
  • 59. Canadian Drug Infusion Systems Market, by Value, 2016-2025 ($million)
  • 60. Canadian Drug Infusion Pumps Market, by Type 2016-2025($million)
  • 61. European Drug Infusion Systems Market,2016-2025 ($Million)
  • 62. European Drug Infusion Systems Market, by Components, 2016-2025 ($Million)
  • 63. Austria Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 64. Austria Drug Infusion Pumps Market, by type 2016-2025($million)
  • 65. Belarus Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 66. Belarus Drug Infusion Pumps Market, by type 2016-2025($million)
  • 67. Belgium Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 68. Belgium Drug Infusion Systems Market, by type 2016-2025
  • 69. Denmark Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 70. Denmark Drug Infusion Systems Market, by type 2016-2025
  • 71. Finland Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 72. Finland Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 73. France Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 74. France Drug Infusion Pumps Market, by volume 2016-2025 ($million)
  • 75. Germany Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 76. Germany Drug Infusion Pumps Market, by type 2016-2025 ($million)
  • 77. Greece Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 78. Greece Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 79. Hungary Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 80. Hungary Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 81. Ireland Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 82. Ireland Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 83. Italy Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 84. Italy Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 85. Luxembourg Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 86. Luxembourg Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 87. Netherlands Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 88. Netherlands Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 89. Norway Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 90. Norway Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 91. Poland Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 92. Poland Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 93. Portugal Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 94. Portugal Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 95. Russia Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 96. Russia Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 97. Spain Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 98. Spain Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 99. Sweden Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 100. Sweden Drug Infusion Pumps Market, by type 2016-2025 ($million)
  • 101. Switzerland Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 102. Switzerland Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 103. Turkey Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 104. Turkey Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 105. Ukraine Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 106. Ukraine Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 107. The U.K. Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 108. The U.K. Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 109. Asia Pacific Drug Infusion Systems Market, 2016-2025, ($Million)
  • 110. Asia Pacific Drug Infusion Systems Market, by Component, 2016-2025 ($Million)
  • 111. Australian Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 112. Australian Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 113. Asia Pacific Drug Infusion Systems Market, by Component, 2016-2025 ($Million)
  • 114. Australian Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 115. Australian Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 116. Bangladesh Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 117. Bangladesh Drug Infusion Pumps Market, by type 2016-2025 ($million)
  • 118. China Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 119. China Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 120. Hong Kong Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 121. Hong Kong Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 122. India Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 123. India Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 124. Indonesia Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 125. Indonesia Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 126. Japan Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 127. Japan Drug Infusion Systems Market, by type 2016-2025($million)
  • 128. South Korea Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 129. South Korea Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 130. Malaysia Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 131. Malaysia Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 132. New Zealand Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 133. New Zealand Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 134. Pakistan Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 135. Pakistan Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 136. Philippines Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 137. Philippines Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 138. Singapore Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 139. Singapore Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 140. Taiwan Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 141. Taiwan Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 142. Thailand Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 143. Thailand Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 144. Vietnam Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 145. Vietnam Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 146. Latin America Drug Infusion Systems Market, 2016-2025 ($million)
  • 147. Latin America Drug Infusion Systems Market, by Components 2016-2025 ($million)
  • 148. Argentina Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 149. Argentina Drug Infusion Pumps Market, by type 2016-2025 ($million)
  • 150. Brazil Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 151. Brazil Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 152. Chile Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 153. Chile Drug Infusion Pumps Market, by type 2016-2025 ($million)
  • 154. Colombia Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 155. Colombia Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 156. Mexico Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 157. Mexico Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 158. MEA Drug Infusion Systems Market, 2016-2025 ($million)
  • 159. MEA Drug Infusion Systems Market, by Component 2016-2025 ($million)
  • 160. Egypt Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 161. Egypt Drug Infusion Systems Market, by type, 2016-2025 ($million)
  • 162. Iran Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 163. Iran Drug Infusion Pumps Market, by type, 2016-2025 ($million)
  • 164. Israel Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 165. Israel Drug Infusion Systems Market, by type 2016-2025
  • 166. Kenya Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 167. Kenya Drug Infusion Systems Market, by type, 2016-2025 ($million)
  • 168. Kuwait Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 169. Kuwait Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 170. Nigeria Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 171. Nigeria Drug Infusion Pumps Market, by type, 2016-2025 ($million)
  • 172. Oman Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 173. Oman Drug Infusion Systems Market, by type, 2016-2025 ($million)
  • 174. Qatar Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 175. Qatar Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 176. Saudi Arabia Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 177. Saudi Arabia Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 178. South Africa Drug Infusion Pumps Market, by value, 2016-2025 ($million)
  • 179. South Africa Drug Infusion Systems Market, by type 2016-2025 ($million)
  • 180. United Arab Emirates Drug Infusion Systems Market, by value, 2016-2025 ($million)
  • 181. United Arab Emirates Drug Infusion Pumps Market, by type 2016-2025 ($million)
  • 182. Arcomed AG: Overall Product Portfolio
  • 183. Arcomed AG: Product Portfolio of Drug Infusion Systems
  • 184. Arcomed AG: SWOT Analysis
  • 185. B.Braun Melsungen AG: Overall Product Portfolio
  • 186. B.Braun Melsungen AG: Product Portfolio of Drug Infusion Systems
  • 187. B. Braun Melsungen AG: Overall Financials (2014-2016)
  • 188. B. Braun Melsungen AG: Net Revenue by Region (2014-2016)
  • 189. B. Braun Melsungen AG: Revenue by Division (2014-2016)
  • 190. B.Braun Melsungen AG:Global Presence
  • 191. B. Braun Melsungen AG: SWOT Analysis
  • 192. Baxter International Inc.: Overall Product Portfolio
  • 193. Baxter International Inc. : Product Portfolio of Drug Infusion Systems
  • 194. Baxter International Inc.: Overall Financials (2014-2016)
  • 195. Baxter International Inc.: Net Revenue by Region (2014-2016)
  • 196. Baxter International Inc.: Revenue by Segment (2014-2016)
  • 197. Baxter International Inc.: Revenue By Hospital Products Sub-Segment (2014-2016)
  • 198. Baxter International Inc: Global Presence
  • 199. Baxter International Inc.: SWOT Analysis
  • 200. Becton, Dickinson and Company: Overall Product Portfolio
  • 201. Becton, Dickinson and Company: Overall Financials (2015-2017)
  • 202. Becton, Dickinson and Company: Net Revenue by Region (2015-2017)
  • 203. Becton, Dickinson and Company: Revenue by Business Segment (2015-2017)
  • 204. Becton, Dickinson and Company: Revenue by Sub-Segment (2015-2017)
  • 205. Becton, Dickinson and Company: Global Presence
  • 206. Becton, Dickinson and Company: SWOT Analysis
  • 207. Caesarea Medical Electronics Ltd.: Overall Product Portfolio
  • 208. Caesarea Medical Electronics Ltd.: Product Portfolio
  • 209. Caesarea Medical Electronics Ltd.: SWOT Analysis
  • 210. Debiotech S.A.: Overall Product Portfolio
  • 211. Product Portfolio for Debiotech Technologies Segment
  • 212. Debiotech S.A.: SWOT Analysis
  • 213. Flowonix Medical Inc.: Overall Product Portfolio
  • 214. Flowonix Medical Inc.: Drug Infusion Systems Product Portfolio
  • 215. Flowonix Medical Inc.: SWOT Analysis
  • 216. Fresenius SE & Co. KGaA: Overall Product Portfolio
  • 217. Product Portfolio for Fresenius Kabi
  • 218. Fresenius SE & Co. KGaA: Overall Financials (2014-2016)
  • 219. Fresenius Kabi: Revenue by Region (2014-2016)
  • 220. Fresenius SE & Co. KGaA: Revenue by Segment (2014-2016)
  • 221. Fresenius SE & Co. KGaA: Revenue by Sub-Segment (2014-2016)
  • 222. Fresenius SE & Co. KGaA: Global Presence
  • 223. Fresenius SE & Co. KGaA: SWOT Analysis
  • 224. Halyard Health, Inc.: Overall Product Portfolio
  • 225. Halyard Health, Inc.: Drug Infusion Systems Product Portfolio
  • 226. Halyard Health, Inc.: Overall Financials (2014-2016)
  • 227. Halyard Health, Inc.: Revenue by Region (2015-2017)
  • 228. Halyard Health, Inc.: Revenue by Business Segment (2015-2017)
  • 229. Halyard Health, Inc.: Global Presence
  • 230. Halyard Health, Inc.: SWOT Analysis
  • 231. ICU Medical Inc.: Overall Product Portfolio
  • 232. ICU Medical Inc.: Product Portfolio of Drug Infusion Systems
  • 233. ICU Medical Inc.: Overall Financials (2014-2016)
  • 234. ICU Medical Inc.: Revenue by Segment (2014-2016)
  • 235. ICU Medical Inc.: Revenue by Sub-Segment (2014-2016)
  • 236. ICU Medical Inc.: Global Presence
  • 237. ICU Medical Inc.: SWOT Analysis
  • 238. IRADIMED CORPORATION: Product Portfolio of Drug Infusion Systems
  • 239. IRADIMED CORPORATION: Overall Financials (2014-2016)
  • 240. IRADIMED CORPORATION: Revenue by Region (2014-2016)
  • 241. IRADIMED CORPORATION: Revenue by Business Segment (2015-2017)
  • 242. IRADIMED CORPORATION: Global Presence
  • 243. IRADIMED CORPORATION:SWOT Analysis
  • 244. Insulet Corporation: Overall Product Portfolio
  • 245. Insulet Corporation: Product Portfolio of Drug Infusion Systems
  • 246. Insulet Corporation: Overall Financials (2014-2016)
  • 247. Insulet Corporation: Revenue by Region (2014-2016)
  • 248. Insulet Corporation: Revenue by Business Segment (2014-2016)
  • 249. Insulet Corporation: Global Presence
  • 250. Insulet Corporation: SWOT Analysis
  • 251. Medtronic Public Limited Company: Overall Product Portfolio
  • 252. Medtronic Public Limited Company: Product Portfolio of Drug Infusion Systems
  • 253. Medtronic Public Limited Company: Overall Financials (2015-2017)
  • 254. Medtronic Public Limited Company: Net Revenue by Region (2015-2017)
  • 255. Medtronic Public Limited Company: Revenue by Business Segment (2015-2017)
  • 256. Medtronic Public Limited Company: Revenue by Sub-Segment (2015-2017)
  • 257. Medtronic Public Limited Company: Global Presence
  • 258. Medtronic Public Limited Company: SWOT Analysis
  • 259. MOOG, Inc.: Overall Product Portfolio
  • 260. MOOG, Inc.: Product Portfolio of Drug Infusion Systems
  • 261. MOOG, Inc.: Overall Financials (2015-2017)
  • 262. MOOG, Inc.: Revenue by Segment (2015-2017)
  • 263. MOOG, Inc.: Global Presence
  • 264. MOOG, Inc. SWOT Analysis
  • 265. Smiths Group plc: Overall Product Portfolio
  • 266. Smiths Group plc: Product Portfolio of Drug Infusion Systems
  • 267. Smiths Group plc: Overall Financials (2015-2017)
  • 268. Smiths Group plc: Net Revenue by Region (2015-2016)
  • 269. Smiths Group plc: Net Revenue by Region, 2017
  • 270. Smiths Group plc: Revenue by Division (2015-2017)
  • 271. Smiths Group plc.: Revenue By Smiths Medical Sub-division (2015-2017)
  • 272. Smiths Group plc.: Global Presence
  • 273. Smiths Group plc SWOT Analysis
  • 274. Tandem Diabetes Care, Inc.: Overall Product Portfolio
  • 275. Tandem Diabetes Care, Inc.: Products Under Development
  • 276. Tandem Diabetes Care: Overall Financials (2014-2016)
  • 277. Tandem Diabetes Care: Global Presence
  • 278. Tandem Diabetes Care, Inc.: SWOT Analysis
  • 279. Terumo Corporation: Overall Product Portfolio
  • 280. Terumo Corporation: Product Portfolio of Drug Infusion Systems
  • 281. Terumo Corporation: Overall Financials (2015-2017)
  • 282. Terumo Corporation: Net Revenue by Region (2015-2017)
  • 283. Terumo Corporation: Revenue by Business Segment (2015-2017)
  • 284. Terumo Corporation: Revenue by Sub-Segment (2015-2017)
  • 285. Terumo Corporation: Global Presence
  • 286. Terumo Corporation: SWOT Analysis
  • 287. Zyno Medical, LLC: Overall Product Portfolio
  • 288. Zyno Medical, LLC: Product Portfolio of Drug Infusion Systems
  • 289. Zyno Medical, LLC: SWOT Analysis
  • 290. Global Infusion Systems Market Segmentation
  • 291. Data Triangulation
Back to Top